GLOBAL IMPACT OF THE COVID19 PANDEMIC ON SUBARACHNOID HEMORRHAGE ADMISSIONS, ANEURYSM TREATMENT AND IN-HOSPITAL MORTALITY: 1 YEAR FOLLOW-UP

• Authors: NGUYEN T.N.; QURESHI M.M.; KLEIN P.; MIKULÍK Robert; YAMAGAMI H.; ETMINAN N.; SATHYA A.; ABDALKADER M.; KRISTOFFERSEN E Saxhaug; MANSOUR O.Y.; DEMEESTERE J.; ALPAY K.; LO H.; NAGGARA O.; MOHLENBRUCH M.A.; ACAMPA M.; KARWACKI G.M.; AHMAD S.; MAI T.D.; FALUP-PECURARIU C.; ALL at.
• Year of publication: 2022
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: Background: Prior studies indicated a decrease in the incidences of subarachnoid hemorrhage (SAH) during the early stages of the COVID-19 pandemic. We evaluated differences in the incidence, severity of SAH presentation, and ruptured aneurysm treatment modality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods: We conducted a cross-sectional study including 49 countries and 187 centers. We recorded volumes for: COVID-19 hospitalizations, SAH hospitalizations, Hunt-Hess Grade, coiling, clipping, and aneurysmal SAH (aSAH) in-hospital mortality. Diagnoses were identified by ICD-10 codes or stroke databases from January 2019 to May 2021.